InvestorsHub Logo
Followers 105
Posts 4947
Boards Moderated 0
Alias Born 10/20/2015

Re: abew4me post# 298804

Saturday, 02/13/2021 6:26:06 PM

Saturday, February 13, 2021 6:26:06 PM

Post# of 461255
I believe Anavex patent protection is better than AMRN. I have not looked at AMRN patents but Anavex has a whole suite of patents which provide comprehensive protection IMO. An Anavex Director is a world class patent attorney in the area of pharmaceuticals.
The Coup de Gras of these is the patent on the crystalline form of A2-73 and it's isomers. This is the shelf stable form suitable for pills and no refrigeration. The FDA could not likely find a liquid generic form non-inferior because of the risk of degradation as it moves though the supply chain to the consumer. Also they would have a hard time competing on price as the drug is not expensive to make but the non stable form would be expensive to ship and handle, again with less confidence in a consistent product.
I believe icosapent ethyl (Vascepa) is non-crystalline and stable in its liquid form.
No patent issues at Anavex. Anavex management are practical Cats. Everything is planned and executed to precision.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News